SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001558370-22-005515
Filing Date
2022-04-15
Accepted
2022-04-15 16:01:56
Documents
13
Period of Report
2022-06-27

Document Format Files

Seq Description Document Type Size
1 PRE 14A tmb-20220627xpre14a.htm PRE 14A 1884349
2 GRAPHIC tmb-20220627xpre14a041.jpg GRAPHIC 136172
3 GRAPHIC tmb-20220627xpre14a018.jpg GRAPHIC 944
4 GRAPHIC tmb-20220627xpre14a036.jpg GRAPHIC 5546
5 GRAPHIC tmb-20220627xpre14a014.jpg GRAPHIC 829
6 GRAPHIC tmb-20220627xpre14a020.jpg GRAPHIC 847
7 GRAPHIC tmb-20220627xpre14a002.jpg GRAPHIC 6364
8 GRAPHIC tmb-20220627xpre14a019.jpg GRAPHIC 896
9 GRAPHIC tmb-20220627xpre14a025.jpg GRAPHIC 14958
10 GRAPHIC tmb-20220627xpre14a031.jpg GRAPHIC 41892
11 GRAPHIC tmb-20220627xpre14a010.jpg GRAPHIC 937
12 GRAPHIC tmb-20220627xpre14a040.jpg GRAPHIC 160830
13 GRAPHIC tmb-20220627xpre14a008.jpg GRAPHIC 885
  Complete submission text file 0001558370-22-005515.txt   2398417
Mailing Address B900 BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT
Business Address B900 BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT 011441223261503
BICYCLE THERAPEUTICS plc (Filer) CIK: 0001761612 (see all company filings)

IRS No.: 000000000
Type: PRE 14A | Act: 34 | File No.: 001-38916 | Film No.: 22830054
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences